This is a StreetInsider.com Premium Only Page

(VERU) – StreetInsider.com Reports

Apr 15, 2024 05:50 AM Veru, Inc. (VERU) PT Lowered to $5 at Oppenheimer

Mar 27, 2024 04:23 PM Raymond James Starts Veru, Inc. (VERU) at Outperform

Mar 12, 2024 08:00 AM Veru, Inc. (VERU) Appoints Louis Aronne as Chief Medical Advisor

Feb 27, 2024 08:33 PM Veru (VERU) Receives Nasdaq Non-compliance Notice

Feb 15, 2024 04:54 PM Veru, Inc. (VERU) Announces Delayed 10-Q Filing

Feb 6, 2024 08:30 AM Veru (VERU) Announces FDA Clearance of IND Application to Initiate Phase 2b Trial of Enobosarm

Jan 8, 2024 08:33 AM Veru, Inc. (VERU) Submits IND Application to FDA for the Development of Enobosarm to Prevent Muscle Loss While Augmenting Fat Loss in Combination with GLP-1 Drugs for Weight Loss

Dec 14, 2023 09:01 AM Veru (VERU) Prices 45.83M Share Offering at $0.72/sh

Dec 13, 2023 04:01 PM Veru, Inc. (VERU) Announces Proposed Public Offering of Common Stock

Oct 4, 2023 08:32 AM Veru (VERU) Reports Muscle Data from 5 Clinical Studies of Enobosarm

Sep 26, 2023 08:31 AM Veru (VERU) Reaches Agreement with FDA on New Phase 3 Clinical Trial for Sabizabulin for Broader Indication: Hospitalized Adult Patients with Any Type of Viral ARDS

Sep 11, 2023 07:02 AM Veru, Inc. (VERU) Reports Clinical Data from the Discontinued ARTEST Study of Enobosarm

Aug 14, 2023 08:20 AM Veru, Inc. (VERU) PT Lowered to $7 at Oppenheimer

Aug 10, 2023 06:33 AM Veru, Inc. (VERU) Tops Q3 EPS by 27c

Jun 7, 2023 01:35 AM Jefferies Upgrades Veru, Inc. (VERU) to Hold

Jun 1, 2023 08:32 AM Veru, Inc. (VERU) Appoints Erik Swenson and Robert Schooley to its Board

May 15, 2023 06:38 AM Veru, Inc. (VERU) PT Lowered to $2 at H.C. Wainwright

May 15, 2023 05:48 AM Veru, Inc. (VERU) Announces 5M Share Offering by Selling Stockholders

May 11, 2023 06:45 AM Veru, Inc. (VERU) Misses Q2 EPS by 15c

May 4, 2023 08:32 AM Veru, Inc. (VERU) Reaches Agreement with FDA on Confirmatory Phase 3 Clinical Trial for Sabizabulin

Apr 20, 2023 06:45 AM Veru (VERU) Sells ENTADFI to Blue Water Vaccines (BWV) for Up to $100M

Apr 19, 2023 08:32 AM Veru (VERU) Enters Into Supply Agreement with Afaxys to Expand Access to FC2 Female Condom® in U.S. Public Health Sector

Apr 13, 2023 06:09 AM Veru, Inc. (VERU) Announces 5M Share Offering at $1/sh

Apr 11, 2023 04:48 PM Veru, Inc. (VERU) Files $200M Mixed Shelf

Apr 11, 2023 08:31 AM Veru, Inc. (VERU) Announces Preclinical Study Results that Demonstrate Sabizabulin Inhibits Poxviruses

Apr 10, 2023 06:31 AM Veru, Inc. (VERU) PT Lowered to $6 at H.C. Wainwright

Apr 4, 2023 08:31 AM Veru (VERU) Announces Preclinical Results from Expanded Sabizabulin Program into Influenza-Induced Severe Acute Respiratory Distress Syndrome and Provides Update on COVID-19 Program

Mar 16, 2023 04:15 PM Veru, Inc. (VERU) Files $200M Mixed Shelf

Mar 15, 2023 06:20 AM Veru, Inc. (VERU) PT Lowered to $9 at Oppenheimer

Mar 14, 2023 12:35 PM Veru, Inc. (VERU) is reserving sabizabulin for clinical development only in infectious disease indications

Mar 2, 2023 05:45 PM After-hours stock movers: C3.ai jumps on results, Zscaler falls

Mar 2, 2023 05:35 PM Veru, Inc. (VERU) sinks 40% after-hours after the FDA declined its EUA for sabizabulin as a COVID treatment

Mar 2, 2023 04:02 PM Veru, Inc. (VERU) Says FDA Declined Request for EUA for Sabizabulin for Hospitalized COVID-19 Patients at High Risk for ARDS

Feb 14, 2023 05:19 AM Veru, Inc. (VERU) PT Lowered to $14 at Oppenheimer

Feb 10, 2023 06:31 AM Veru, Inc. (VERU) PT Lowered to $14 at H.C. Wainwright

Feb 9, 2023 10:50 AM Veru, Inc. (VERU) PT Lowered to $15 at Cantor Fitzgerald

Feb 9, 2023 06:34 AM Veru, Inc. (VERU) Misses Q1 EPS by 11c

Feb 8, 2023 02:41 AM Veru, Inc. (VERU) PT Lowered to $2 at Jefferies

Jan 17, 2023 05:53 AM Veru (VERU): Market Continues to Discount sabizabulin - Oppenheimer Reiterates Stock at Buy, $20 Price Target

Jan 13, 2023 05:26 AM Veru, Inc. (VERU) call put ratio 1.6 calls to 1 put

Jan 12, 2023 11:03 AM Veru, Inc. (VERU) receive Notice of Allowance for its US patent related to COVID

Jan 12, 2023 05:15 AM Veru, Inc. (VERU) call put ratio 1.6 calls to 1 put

Jan 11, 2023 04:48 AM Veru, Inc. (VERU) call put ratio 12.5 calls to 1 put

Jan 10, 2023 11:04 AM Veru, Inc. (VERU) call put ratio 14 calls to 1 put into data

Jan 10, 2023 08:30 AM Veru, Inc. (VERU) Appoints David D. Ho as Chairman of its Infectious Disease Scientific Advisory Board

Jan 9, 2023 11:21 AM Veru, Inc. (VERU) call put ratio 19 calls to 1 put

Jan 3, 2023 11:16 AM Veru, Inc. (VERU) call put ratio 3.6 calls to 1 put

Dec 29, 2022 11:04 AM Veru, Inc. (VERU) call put ratio 5 calls to 1 put

Dec 7, 2022 06:33 AM Veru, Inc. (VERU) PT Lowered to $18 at H.C. Wainwright

Dec 5, 2022 10:59 AM Veru, Inc. (VERU) PT Lowered to $22 at Cantor Fitzgerald